Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

This study has been completed.
Information provided by:
Affiris AG Identifier:
First received: July 2, 2007
Last updated: October 18, 2010
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)